Aimmune’s Palforzia

Nestlé successfully completed acquisition of Aimmune Therapeutics

THE FINANCIAL -- Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé…

2 years ago

Nestle announced the results of the tender offer for Aimmune

The FINANCIAL -- Société des Produits Nestlé S.A. ("Nestlé") today announced the results of the tender offer by its wholly-owned…

2 years ago

Nestle to buy Aimmune’s peanut allergy treatment at $2.6 billion

The FINANCIAL -- Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its…

2 years ago